Tavridou A - Search Results

1

G894T polymorphism of eNOS gene is a predictor of response to combination of inhaled corticosteroids with long-lasting β2-agonists in asthmatic children.

Iordanidou M, Paraskakis E, Tavridou A, Paschou P, Chatzimichael A, Manolopoulos VG. Iordanidou M, et al. Among authors: tavridou a. Pharmacogenomics. 2012 Sep;13(12):1363-72. doi: 10.2217/pgs.12.120. Pharmacogenomics. 2012. PMID: 22966886

2

Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19*17 discovery: the case of Greece.

Ragia G, Arvanitidis KI, Tavridou A, Manolopoulos VG. Ragia G, et al. Among authors: tavridou a. Pharmacogenomics. 2009 Jan;10(1):43-9. doi: 10.2217/14622416.10.1.43. Pharmacogenomics. 2009. PMID: 19102714

3

Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.

Ragia G, Petridis I, Tavridou A, Christakidis D, Manolopoulos VG. Ragia G, et al. Among authors: tavridou a. Pharmacogenomics. 2009 Nov;10(11):1781-7. doi: 10.2217/pgs.09.96. Pharmacogenomics. 2009. PMID: 19891554

4

Pharmacogenetics of coumarinic oral anticoagulants.

Manolopoulos VG, Ragia G, Tavridou A. Manolopoulos VG, et al. Among authors: tavridou a. Pharmacogenomics. 2010 Apr;11(4):493-6. doi: 10.2217/pgs.10.31. Pharmacogenomics. 2010. PMID: 20350128

5

Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.

Manolopoulos VG, Ragia G, Tavridou A. Manolopoulos VG, et al. Among authors: tavridou a. Pharmacogenomics. 2011 Aug;12(8):1161-91. doi: 10.2217/pgs.11.65. Pharmacogenomics. 2011. PMID: 21843065 Review.

6

Endothelial nitric oxide synthase gene polymorphisms are associated with sensitization to seasonal aeroallergens in asthmatic children.

Iordanidou M, Paraskakis E, Tavridou A, Chatzimichael A, Manolopoulos VG. Iordanidou M, et al. Among authors: tavridou a. World J Pediatr. 2017 Feb;13(1):34-40. doi: 10.1007/s12519-016-0043-9. Epub 2016 Jun 15. World J Pediatr. 2017. PMID: 27363984

7

Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.

Arvanitidis K, Ragia G, Iordanidou M, Kyriaki S, Xanthi A, Tavridou A, Manolopoulos VG. Arvanitidis K, et al. Among authors: tavridou a. Fundam Clin Pharmacol. 2007 Aug;21(4):419-26. doi: 10.1111/j.1472-8206.2007.00510.x. Fundam Clin Pharmacol. 2007. PMID: 17635181

8

EP2306 and EP2302, two novel squalene synthase inhibitors, stimulate endothelial nitric oxide synthase expression in cultured endothelial cells.

Tavridou A, Megaritis G, Kourounakis AP, Charalambous A, Manolopoulos VG. Tavridou A, et al. Endothelium. 2007 Jul-Oct;14(4-5):239-43. doi: 10.1080/10623320701547216. Endothelium. 2007. PMID: 17922341

9

The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians.

Iordanidou M, Tavridou A, Vasiliadis MV, Arvanitidis KI, Petridis J, Christakidis D, Vargemezis V, Bougioukas G, Manolopoulos VG. Iordanidou M, et al. Among authors: tavridou a. Pharmacogenet Genomics. 2008 Feb;18(2):153-9. doi: 10.1097/FPC.0b013e3282f4ae93. Pharmacogenet Genomics. 2008. PMID: 18192901

10

Inhibitors of 5-lipoxygenase activating protein: WO 2008/030369.

Tavridou A, Manolopoulos VG. Tavridou A, et al. Expert Opin Ther Pat. 2009 Oct;19(10):1473-6. doi: 10.1517/13543770903008569. Expert Opin Ther Pat. 2009. PMID: 19456278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters